Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
D000818:Animals; D000918:Antibody Specificity; D001500:BCG Vaccine; D002478:Cells, Cultured; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology*; D006614:Hindlimb; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D008937:Mitomycins / Q000494:pharmacology; D009163:Mycobacterium bovis / Q000276:immunology; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000008:administration & dosage / Q000494:pharmacology*; D012513:Sarcoma, Experimental / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014734:Vibrio cholerae / Q000201:enzymology
D001500:BCG Vaccine; D008937:Mitomycins; D008748:Methylcholanthrene; D009439:Neuraminidase